These are some very interesting statistics Jag and I'll be following them closely in future, especially to see if my hypothesis that ' a snowball in clinical evidence will precede a snowball in usage and revenues.' Are we seeing the first signs of this now? Too early to tell and I'd like the figures we're given by the company to be more precise although your statistics and some other indicators give me hope.
I'm going to get really excited though when we start seeing those quarterly revenue figures for CardioCel growing at >50% quarter on quarter.
Around 3mil shares buy order by one on 63, page-136
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.00 |
Change
1.100(9.24%) |
Mkt cap ! $274.7M | |||
| Open | High | Low | Value | Volume |
| $12.00 | $13.20 | $12.00 | $718.4K | 56.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 680 | $13.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.25 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |